Mary Beth Dwyer

Senior Neurology Account Manager @Greenwich Biosciences

Launched first and only FDA-approved cannabinoid therapy (Epidiolex) for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome and Tuberous Sclerosis Complex and started the U.S. commercial affiliate.Marketing Field Advisory Board - as a member of the first advisory board, I collaborated with the U.S. marketing team on various initiative for a two year rotation. 20••••21Specialty Pharmacy - on-boarding of local facilities in the Kentucky market. 2019-presentPharmaCord - assisted in on-boarding the national integrated solutions team to assist in patient access.Segmentation Liaison - worked with selected leadership members and outside agency in a one year provider segmentation provider. 2019VEEVA Development - worked with our I.T department to enhance our C.R.M platform. 2018-presentMarket Access Liaison Committee Regional Lead - inaugural member. 2021-present